Cargando…

Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Sarah S., Smith, Becky A., Akinboyo, Ibukunoluwa C., Seidelman, Jessica, Wolfe, Cameron, Kirk, Allan B., Martin, Gavin, Denny, Thomas, Lobaugh, Bruce, Rehder, Catherine, Cardona, Diana, Lee, Mark J., Polage, Christopher R., Datto, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450245/
https://www.ncbi.nlm.nih.gov/pubmed/32741409
http://dx.doi.org/10.1017/ice.2020.398
_version_ 1783574777501319168
author Lewis, Sarah S.
Smith, Becky A.
Akinboyo, Ibukunoluwa C.
Seidelman, Jessica
Wolfe, Cameron
Kirk, Allan B.
Martin, Gavin
Denny, Thomas
Lobaugh, Bruce
Rehder, Catherine
Cardona, Diana
Lee, Mark J.
Polage, Christopher R.
Datto, Michael B.
author_facet Lewis, Sarah S.
Smith, Becky A.
Akinboyo, Ibukunoluwa C.
Seidelman, Jessica
Wolfe, Cameron
Kirk, Allan B.
Martin, Gavin
Denny, Thomas
Lobaugh, Bruce
Rehder, Catherine
Cardona, Diana
Lee, Mark J.
Polage, Christopher R.
Datto, Michael B.
author_sort Lewis, Sarah S.
collection PubMed
description We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.
format Online
Article
Text
id pubmed-7450245
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-74502452020-08-27 Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area Lewis, Sarah S. Smith, Becky A. Akinboyo, Ibukunoluwa C. Seidelman, Jessica Wolfe, Cameron Kirk, Allan B. Martin, Gavin Denny, Thomas Lobaugh, Bruce Rehder, Catherine Cardona, Diana Lee, Mark J. Polage, Christopher R. Datto, Michael B. Infect Control Hosp Epidemiol Concise Communication We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members. Cambridge University Press 2020-08-03 /pmc/articles/PMC7450245/ /pubmed/32741409 http://dx.doi.org/10.1017/ice.2020.398 Text en © The Society for Healthcare Epidemiology of America 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Concise Communication
Lewis, Sarah S.
Smith, Becky A.
Akinboyo, Ibukunoluwa C.
Seidelman, Jessica
Wolfe, Cameron
Kirk, Allan B.
Martin, Gavin
Denny, Thomas
Lobaugh, Bruce
Rehder, Catherine
Cardona, Diana
Lee, Mark J.
Polage, Christopher R.
Datto, Michael B.
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
title Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
title_full Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
title_fullStr Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
title_full_unstemmed Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
title_short Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
title_sort early experience with universal preprocedural testing for sars-cov-2 in a relatively low-prevalence area
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450245/
https://www.ncbi.nlm.nih.gov/pubmed/32741409
http://dx.doi.org/10.1017/ice.2020.398
work_keys_str_mv AT lewissarahs earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT smithbeckya earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT akinboyoibukunoluwac earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT seidelmanjessica earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT wolfecameron earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT kirkallanb earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT martingavin earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT dennythomas earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT lobaughbruce earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT rehdercatherine earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT cardonadiana earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT leemarkj earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT polagechristopherr earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea
AT dattomichaelb earlyexperiencewithuniversalpreproceduraltestingforsarscov2inarelativelylowprevalencearea